Several biological markers such as estrogen receptor alpha (ERα), progesterone receptor (PR), and the ErbB family of receptor tyrosine kinases have been evaluated by means of immunohistochemistry in non-palpable breast carcinomas and found to correlate with mammographic findings of higher risk such as MAMCs [12,13]. The gene discussed is ESR1; the disease is breast carcinoma.